Reports
Sale
Global Alopecia Market Share, Size, Growth, Analysis: By Disease Type: Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis, Others; By Treatment: Localized Therapies, Systemic Therapies, Others; By Route of Administration; By Gender; By Distributional Channel; Regional Analysis; Supplier Landscape; 2024-2032
Global Alopecia Market Outlook
The global alopecia market size attained a value of USD 3.58 billion in 2023. The major driver of the market includes the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses. The market is anticipated to grow at a CAGR of 8.6% during the forecast period of 2024-2032 to attain a value of USD 9.60 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
There are many different kinds of alopecia, each with a distinct cause. As is prevalent in male pattern baldness, alopecia can be located at the front and top of the head. It may be patchy as in an alopecia areata disorder. The alopecia market can be divided on the basis of segments like disease type, drug type, route of administration, gender, and distribution channel.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global alopecia market can be broadly categorised on the basis of disease type into:
- Androgenic Alopecia
- Alopecia Areata
- Ciatricial Alopecia
- Traction Alopecia
- Alopecia Totalis
The industry can be divided on the basis of drug type as:
- Minoxidil
- Finasteride
- Others
The global alopecia market can be categorised based on route of administration as:
- Oral
- Topical
- Injectable
The industry can be divided based on gender as:
- Males
- Females
The global alopecia market can be divided on the basis of the distribution channel as:
- Hospitals
- Retail Pharmacies
- Online Pharmacies
The EMR report looks into the regional markets of alopecia like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Alopecia Market Analysis
It is expected that the occurrence of Polycystic Ovary Syndrome (PCOS), cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses will drive the global alopecia market. Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are regarded as powerful triggers for alopecia. While the precise causative factors stay unknown, genetic factors are associated with several instances. Increasing disposable earnings and increasing emphasis on aesthetic appearances are anticipated to contribute to the demand for therapy of alopecia. Hormonal imbalance and ageing accelerate the growth of hair loss instances, further aiding the global alopecia market growth. The overall increase in the geriatric population and rising customer consciousness of therapy alternatives are also anticipated to have a positive impact on the global alopecia market in the following years. During the forecast period, the product development of new therapeutic alternatives is anticipated to drive the industry growth. Other factors driving the industry include the introduction of fast-acting JAK inhibitors, the development of techniques to boost hair growth using human pluripotent stem cells, and PRP therapy.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global alopecia market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Cipla Ltd.
- Capillus LLC
- Freedom Laser Therapy, Inc.
- Apira Science, Inc.
- HairMax (Lexington Intl., LLC)
- Follica, Inc.
- Incyte Corporation
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Type |
|
| Breakup by Treatment |
|
| Breakup by Route of Administration |
|
| Breakup by Gender |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Alopecia Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Alopecia Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Alopecia Epidemiology (2016-2031)
5.3 Europe Alopecia Epidemiology (2016-2031)
5.4 Asia-Pacific Alopecia Epidemiology (2016-2031)
5.5 Latin America Alopecia Epidemiology (2016-2031)
5.6 Middle East & Africa Alopecia Epidemiology (2016-2031)
6 Global Alopecia Market Overview
6.1 Global Alopecia Market Historical Value (2017-2023)
6.2 Global Alopecia Market Forecast Value (2024-2032)
7 Global Alopecia Market Landscape
7.1 Alopecia: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Alopecia: Product Landscape
7.2.1 Analysis by Type Disease
7.2.2 Analysis by Treatment
7.2.3 Analysis by Applications
7.2.4 Analysis by Route of Administration
7.2.5 Analysis by Gender
7.2.6 Analysis by Distribution Channel
7.2.7 Analysis by End User
8 Alopecia Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Alopecia Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Alopecia Market Segmentation
11.1 Global Alopecia Market by Disease Type
11.1.1 Market Overview
11.1.2 Androgenic Alopecia
11.1.3 Alopecia Areata
11.1.4 Cicatricial Alopecia
11.1.5 Traction Alopecia
11.1.6 Alopecia Totalis
11.1.7 Others
11.2 Global Alopecia Market by Treatment
11.2.1 Market Overview
11.2.2 Localized Therapies
11.2.3 Systemic Therapies
11.2.4 Medical Devices
11.2.5 Herbal Treatment
11.2.6 Others
11.3 Global Alopecia Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Topical
11.3.4 Parenteral
11.4 Global Alopecia Market by Gender
11.4.1 Market Overview
11.4.2 Males
11.4.3 Female
11.5 Global Alopecia Market by Distribution Channel
11.5.1 Market Overview
11.5.2 Hospitals
11.5.3 Retail Pharmacies
11.5.4 Online Pharmacies
11.6 Global Alopecia Market by End User
11.6.1 Market Overview
11.6.2 Hospitals
11.6.3 Healthcare and Dermatology Centers
11.6.4 Homecare
11.6.5 Others
11.7 Global Alopecia Market by Region
11.7.1 Market Overview
11.7.2 North America
11.7.3 Europe
11.7.4 Asia Pacific
11.7.5 Latin America
11.7.6 Middle East and Africa
12 North America Alopecia Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Alopecia Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Alopecia Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Alopecia Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Alopecia Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Cipla Ltd.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Capillus LLC
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Freedom Laser Therapy, Inc.
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Apira Science, Inc.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 HairMax (Lexington Intl., LLC)
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Follica, Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Incyte Corporation
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Novartis International AG
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Sanofi S.A.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Merck & Co. Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Gerolymatos International SA
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Taisho Pharmaceutical Holdings Co., Ltd.
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Dr. Reddy’s Laboratories Ltd.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 WOCKHARDT
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 Teva Pharmaceuticals USA, Inc.
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
24 Alopecia - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
Globally, alopecia market reached a value of USD 3.58 billion in 2023.
The market is projected to expand at a CAGR of 8.6% from 2024 to 2032, growing to USD 9.60 billion by 2032.
The major driver of the market includes the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses.
Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The major disease types of alopecia in the market are androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis.
The significant drug types in the industry are minoxidil and finasteride, among others.
The leading routes of administration in the market are oral, topical, and injectable.
The major gender segments in the industry are males and females.
The significant distribution channels in the market are hospitals, retail pharmacies, and online pharmacies.
The major players in the industry are Cipla Ltd., Capillus LLC, Freedom Laser Therapy, Inc., Apira Science, Inc., HairMax (Lexington Intl., LLC), Follica, Inc., and Incyte Corporation, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER